Diagnostic significance of secondary bacteremia in patients with COVID-19
暂无分享，去创建一个
S. Miyano | S. Imoto | S. Ogawa | Yotaro Takaku | K. Kataoka | H. Ono | S. Hashimoto | H. Namkoong | M. Ishii | A. Kumanogoh | H. Ishikura | Y. Nakamori | Tomohisa Shoko | N. Harada | S. Fujitani | Y. Tanino | T. Yoshiyama | T. Kagaya | Akiko Fujiwara | T. Takano | Y. Mutoh | E. Hagiwara | H. Kitamura | Hirohito Sano | T. Takata | N. Miyazawa | Yu Kusaka | Hiroyuki Kokutou | N. Hashimoto | A. Kawana | Shinji Ogura | S. Abe | K. Kawamura | N. Mori | T. Ishiguro | K. Masaki | Hiroki Watanabe | T. Ishii | Y. Kimizuka | T. Asakura | H. Kamata | Akinori Kimura | T. Odani | Kensuke Nakagawara | S. Chubachi | S. Azekawa | Shiro Otake | Hiroko Watanabe | Yuki Sato | T. Ono | M. Tani | Y. Chihara | Toshiyuki Kita | A. Endo | Masumi Ai | Takahiro Fukushima | H. Muranaka | Y. Matsushita | Y. Nagasaki | R. Edahiro | A. Ando | N. Hasegawa | S. Ueda | Masaki Okamoto | T. Tsuchida | Hiromu Tanaka | A. Morita | Ho Lee | K. Fukunaga | N. Kuwahara | Shuko Mashimo | Y. Hosoda | T. Mochimaru | Fukuki Saito | M. Fukui | Toshiro Sato | Y. Kitagawa | K. Murakami | T. Ohba | Mayuko Watase | Tetsuya Ueda | R. Koike | K. Tokunaga | M. Miyawaki | Yoshinori Hasegawa | Yasuhiro Kimura | Koichi Nishi | Masaru Amishima | Makoto Masuda | Y. Kasamatsu | M. Kuramochi | Kazuhiko Katayama | T. Kanai | Yutaka Kono | Yuichiro Kitagawa | Y. Sato | Tatsuya Kusumoto | Y. Shirai | Yukinori Okada | Ryoichi Otsuki | Shuhei Azekawa | Akifumi Endo
[1] M. Kanai,et al. DOCK2 is involved in the host genetics and biology of severe COVID-19 , 2022, Nature.
[2] A. Giacomelli,et al. Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study , 2022, Infection.
[3] Y. Okada,et al. Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19 , 2021, International Journal of Infectious Diseases.
[4] Michael I. Oppenheim,et al. Hospital-Acquired Bloodstream Infections in Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019): Association With Immunosuppressive Therapies , 2021, Open forum infectious diseases.
[5] E. Sklan,et al. Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients , 2021, Scientific Reports.
[6] M. Kanai,et al. Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan , 2021, medRxiv.
[7] Urvish K. Patel,et al. Kidney disease and COVID-19 disease severity—systematic review and meta-analysis , 2021, Clinical and Experimental Medicine.
[8] S. Zakynthinos,et al. ICU-acquired bloodstream infections in critically ill patients with COVID-19☆ , 2020, Journal of Hospital Infection.
[9] A. Lazzarin,et al. Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] C. Ayers,et al. Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry. , 2020, Circulation.
[11] Felipe García,et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study , 2020, Clinical Microbiology and Infection.
[12] W. Lim,et al. Co-infections in people with COVID-19: a systematic review and meta-analysis , 2020, Journal of Infection.
[13] R. Pranata,et al. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[14] R. Pranata,et al. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis , 2020, The American Journal of Emergency Medicine.
[15] W. Lim,et al. Dexamethasone in Hospitalized Patients with Covid-19 , 2021 .